Jun Liang, Ph.D.
Jun has a strong background in tissue-based companion diagnostics, drug discovery and clinical trial design. He has significant experience in the development of integrated scientific and technical tools investigating pharmacogenomic attributes of gene therapy, antibody, nucleotide therapeutics for blood cancers and other rare diseases. At Vertex Pharmaceuticals, he supported both early- and late-stage process development in GLP/GMP environments, providing strategic decision making on development of molecular and cellular bioassays assessing off-target engagement, biodistribution, PK/PD. He focuses on creating effective drug development approaches to progress miRecule’s FSHD program.